Evidence map›Paper›PMID 30151192›Full record

ArticleMultidisciplinary respiratory medicine2018

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Stefano Aliberti, Luigi Ruffo Codecasa, Andrea Gori, Giovanni Sotgiu, Maura Spotti, Antonio Di Biagio, Andrea Calcagno, Stefano Nardini, Baroukh Maurice Assael, Enrico Tortoli and 21 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Multidisciplinary respiratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03339063 unknown statusnot on this map

The Italian Registry of Pulmonary Non-tuberculous Mycobacteria

Typeobservational_patient_registrySponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoRan2017 to 2022Enrolled500ConditionsNontuberculous Mycobacteria
NCT06764576 recruitingnot on this mapstarted 2021, after this paper: background citation

Epidemiological, Demographic and Clinical Aspects of Patients With Tuberculosis, Mycobacteriosis or Infection Latent Tuberculosis

TypeobservationalSponsorIRCCS Azienda Ospedaliero-Universitaria di BolognaRan2021 to 2026Enrolled13,000ConditionsMycobacterial Infection, Tuberculosis (TB)
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Journal of bacteriology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 15 institutions in 5 countries.

Stefano Aliberti1Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122 Milan, Italy.
Luigi Ruffo CodecasaRegional TB Reference Centre, Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Andrea Gori4Clinic of Infectious Diseases, 'San Gerardo" Hospital-ASST Monza, University Milano-Bicocca, Milan, Italy.
Giovanni Sotgiu5Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
Maura Spotti1Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122 Milan, Italy.
Antonio Di Biagio6Clinica Malattie Infettive, Policlinico Ospedale S. Martino, Genoa, Italy.
Andrea Calcagno7Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
Stefano Nardini8Ospedale Civile, Pulmonary and TB Unit, Vittorio Veneto, Italy.
Baroukh Maurice Assael1Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122 Milan, Italy.
Enrico Tortoli9Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Giorgio BesozziStopTB Italia, Milan, Italy.
Maurizio FerrareseRegional TB Reference Centre, Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Alberto Matteelli11WHO Collaborating Centre for TB/HIV co-infection and TB Elimination, Department of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy.
Enrico GirardiClinical Epidemiology Unit, National Institute for Infectious Disease "L. Spallanzani, Rome, Italy.
Saverio De LorenzoE. Morelli Hospital ASST, Reference Center for MDR-TB and HIV-TB, Sondalo, Italy.
Manuela Seia14Medical Genetics Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Andrea Gramegna1Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122 Milan, Italy.
Bruno Del Prato15Unit of Interventional Pulmonology, High Speciality "A. Cardarelli" Hospital, Naples, Italy.
Leonardo Terranova16Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.
Martina Oriano1Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122 Milan, Italy.
Nicola Sverzellati17Scienze Radiologiche, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma, Italy.
Mehdi Mirsaeidi18Miami Veterans Administration Medical Center, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Miami School of Medicine, Miami, FL USA.
James D ChalmersScottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Charles S Haworth20Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.
Michael R Loebinger21Host Defence Clinic, Royal Brompton Hospital, London, UK.
Timothy Aksamit22Mayo Clinic College of Medicine, Rochester, MN USA.
Kevin Winthrop23Oregon Health and Science University, Portland, OR USA.
Felix C Ringshausen24Dept of Respiratory Medicine, Member of the German Centre for Lung Research, Hannover Medical School, Hannover, Germany.
Giuliana PrevidiAziende Socio Sanitarie Territoriale Melegnano e della Martesana, Vizzolo Predabissi, Milan, Italy.
Francesco Blasi1Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122 Milan, Italy.
IRENE Network
University of Milan · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITMayo Clinic · USUniversity of Parma · ITUniversity of Sassari · ITVita-Salute San Raffaele University · ITMedizinische Hochschule Hannover · DEOregon Health & Science University · USOspedale Policlinico San Martino · ITPapworth Hospital · GBTorino e-district · ITUniversity of Dundee · GBUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA substantial increase in pulmonary and extra-pulmonary diseases due to non-tuberculous mycobacteria (NTM) has been documented worldwide, especially among subjects suffering from chronic respiratory diseases and immunocompromised patients. Many questions remain regarding the epidemiology of pulmonary disease due to NTM (NTM-PD) mainly because reporting of NTM-PD to health authorities is not mandated in several countries, including Italy. This manuscript describes the protocol of the first Italian registry of adult patients with respiratory infections caused by NTM (IRENE).

methodsIRENE is an observational, multicenter, prospective, cohort study enrolling consecutive adult patients with either a NTM respiratory isolate or those with NTM-PD. A total of 41 centers, including mainly pulmonary and infectious disease departments, joined the registry so far. Adult patients with all of the following are included in the registry: 1) at least one positive culture for any NTM species from any respiratory sample; 2) at least one positive culture for NTM isolated in the year prior the enrolment and/or prescribed NTM treatment in the year prior the enrolment; 3) given consent to inclusion in the study. No exclusion criteria are applied to the study. Patients are managed according to standard operating procedures implemented in each IRENE clinical center. An online case report form has been developed to collect patients' demographics, comorbidities, microbiological, laboratory, functional, radiological, clinical, treatment and outcome data at baseline and on an annual basis. An IRENE biobank has also been developed within the network and linked to the clinical data of the registry.

conclusionsIRENE has been developed to inform the clinical and scientific community on the current management of adult patients with NTM respiratory infections in Italy and acts as a national network to increase the disease's awareness.

trial registrationClinicaltrial.gov: NCT03339063.

Indexed as

Atypical mycobacteriaBronchiectasisCOPDCystic fibrosisHIVLung transplantM. AviumM. IntracellulareNTM, NTM-PD

Identifiers

PMID30151192
PMCPMC6101082
OpenAlexW2887507451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.